Cannabidiol or CBD is undoubtedly the breakout product of the decade. Although it’s been legal for only a year, the market for CBD is already worth billions, and industry players expect it to hit $20 billion by 2020. It’s extracted from hemp, a variety of cannabis with less than 0.3% THC levels, as mandated by the 2018 Farm Bill.
The chemical is said to be a potent natural medicine, with users claiming it offers relief from a variety of ailments ranging from anxiety and chronic pain to high blood pressure. Still, there’s very little scientific research to back these claims up, and although the FDA has explicitly stated…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.